Abbvie Inc
NYSE:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbvie Inc
NYSE:ABBV
|
US |
|
R
|
Ricoh Co Ltd
F:RIC1
|
JP |
|
C
|
Conduent Inc
SWB:4C0
|
US |
|
M
|
Mitsubishi Chemical Holdings Corp
OTC:MTLHF
|
JP |
|
N
|
Nanosonics Ltd
SWB:OQS
|
AU |
|
G
|
Genesis AI Corp
CNSX:AIG
|
CA |
|
T
|
Technogym SpA
XBER:TN2
|
IT |
|
I
|
Intertek Group PLC
SWB:IT1
|
UK |
|
P
|
Peninsula Energy Ltd
OTC:PENMF
|
AU |
|
L
|
Leonardo SpA
XBER:FMNB
|
IT |
|
M
|
Mit SIM SpA
MIL:MTS
|
IT |
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
MIL:MUV2
|
DE |
|
V
|
Vesuvius PLC
OTC:CKSNF
|
UK |
|
MorphoSys AG
XETRA:MOR
|
DE |
|
M
|
Merck & Co Inc
XBER:6MK
|
US |
|
B
|
B2Gold Corp
XMUN:5BG
|
CA |
|
IFAST Corporation Ltd
F:1O3
|
SG |
|
Y
|
Yangtze Optical Fibre and Cable Joint Stock Ltd Co
XBER:1YO
|
CN |
|
A
|
Arkema SA
XMUN:V1S
|
FR |
|
Eurofins Scientific SE
F:ESF0
|
LU |
|
Hooker Furnishings Corp
NASDAQ:HOFT
|
US |
|
Brightstar Resources Ltd
OTC:BTRAF
|
AU |
|
GDI Integrated Facility Services Inc
F:GQN2
|
CA |
|
E
|
Eurofins Scientific SE
XBER:ESF0
|
LU |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 260.58 USD with a low forecast of 198.74 USD and a high forecast of 344.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
260.58
USD
According to Wall Street analysts, the average 1-year price target for ABBV is 260.58 USD with a low forecast of 198.74 USD and a high forecast of 344.4 USD.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Abbvie Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Abbvie Inc?
Projected CAGR
82%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 82%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 8 years is 31%.
